Skip to content

Effects of Aerobic Exercise on Cognitive Impairment in Patients with Alzheimer's Disease

Effects of Aerobic Exercise on Cognitive Impairment in Patients with Alzheimer's Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-15007420
Enrollment
Unknown
Registered
2015-11-09
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer‘s Disease

Interventions

1:cycling
3:cycling
4:walking
5:aerobic dancing
6 MCI:Best training program
7 mild AD:Best training program
8 Moderate and severe AD:Best training program
9 healthy older adults:Best training program
10 Healthy older adults control:education

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patients aged 50 to 85 (men or women); (2) The patient voluntarily participated in the trial and signed the informed consent, and the caregiver participated as a supervisor; (3) The patients meeting the AD or MCI diagnostic criteria according to the recent diagnosis criteria of American published in 2011; (4) Stable clinical condition; (5) The CT scan or MRI was done in one-year and was accordant with the diagnosis; (6) MoCA Beijing version scores>=10 and <=24; (7) Had more than six years education and was able to read and communicate before dementia; (8) The patient was able to complete all the study procedure and had the support from his/her caregiver; (9) The patient live with his/her caregiver or if he/she lived alone, he/she was able to communicate with the caregiver.

Exclusion criteria

Exclusion criteria: (1) Severe dysfunction of cardiac, pulmonary, nephric systems; (2) The patients who has been diagnosis of Vascular Dementia (VD) by the NINDS-AIREN criteria for Vascular Dementia; (3) Hachinski Ischemic score (HIS) scale score 4; (4) Severe depression, schizophrenia, or other neurodegenerative dementia according to DSM-IV; (5) The patients had other neurological disease or other disease which could affect the neurological performance including moderate or severe pneumonia, Vitamin 12 deficiency or folic acid deficiency, un-controlled diabetes, active hyperthyroidism or hypothyroidism, cerebral vascular diseases including TIA, ischemic stroke and aneurism, alcoholic dementia, un-controlled epilepsia and autoimmune disease such as multiple sclerosis; (6) The patient can not cooperate with cognitive assessments (blindness, deafness, severe aphasia); (7) Weight 160/100mmHg.

Design outcomes

Primary

MeasureTime frame
ADAS-cog;MMSE;MOCA;ADCS-ADL;Barthel Index;NPI;

Secondary

MeasureTime frame
Blood biochemistry;Blood routine;Urine Routine;EKG;Stree test;

Countries

China

Contacts

Public ContactWang Tong
wangtong60621@163.com+86 13951680478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026